Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Jose Luis Dapena Díaz"'
Autor:
Jordi Yagüe, Dhaarini Murugan, José Sanchez de Toledo Codina, Christina Díaz de Heredia Rubio, Dietmar Pfeifer, Ivo P. Touw, Christoph Klein, Jacek Puchałka, Musa Karakukcu, Alexa Triot, Juan I. Aróstegui, Turkan Patiroglu, Jose Luis Dapena Díaz, Daniel Kotlarz, E. Michael Gertz, Päivi M Järvinen, Ekrem Unal, Alejandro A. Schäffer, Mehmet Akif Ozdemir, Tomas Racek, Naschla Kohistani
Publikováno v:
Blood
Blood, 123(24), 3811-3817. American Society of Hematology
Blood, 123(24), 3811-3817. American Society of Hematology
Severe congenital neutropenia (SCN) is characterized by low numbers of peripheral neutrophil granulocytes and a predisposition to life-threatening bacterial infections. We describe a novel genetic SCN type in 2 unrelated families associated with rece
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::645f076efa8d1947268a137c82181e1c
https://doi.org/10.1182/blood-2013-11-535419
https://doi.org/10.1182/blood-2013-11-535419
Autor:
Ekrem Unal, Tomas Racek, Jose Luis Dapena Díaz, Jordi Yagüe, Musa Karakukcu, José Sanchez de Toledo Codina, Turkan Patiroglu, Päivi M Järvinen, Naschla Kohistani, Alexa Triot, Cristina Diaz de Heredia Rubio, Christoph Klein, Mehmet Akif Ozdemir, E. Michael Gertz, Jacek Puchałka, Juan I. Aróstegui, Alejandro A. Schäffer
Severe congenital neutropenia (SCN) is a heterogeneous group of disorders characterized by defective production and viability of neutrophil granulocytes and predisposition to life-threatening bacterial infections. Currently, OMIM lists five defined m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::67e5dbe9b5ca350b88d38ca8b7e19102
https://avesis.erciyes.edu.tr/publication/details/c5d97b5d-921a-4baa-a3ac-02e19ccf357f/oai
https://avesis.erciyes.edu.tr/publication/details/c5d97b5d-921a-4baa-a3ac-02e19ccf357f/oai
Autor:
Paula Gebellí Jové, Nazaret Sánchez Sierra, Ana Sangrós Gimenez, José Luis Dapena Díaz, Nuria Conde Cuevas
Publikováno v:
Anales de Pediatría, Vol 97, Iss 6, Pp 429-430 (2022)
Externí odkaz:
https://doaj.org/article/138b64ac03e9427b86c32aa24da0222c
Autor:
Angeles Bendaña, Manuel Pérez-Encinas, Jose Luis Dapena Díaz, Marta Anna Sobas, Jose Luis Bello-Lopez, Teresa González, Celsa Quinteiro, Natalia Alonso, Maria-Jose Rabuñal, Marta González
Publikováno v:
Blood. 114:1898-1898
Abstract 1898 Poster Board I-921 Introduction: JAK2V617F mutation is detected in more than 90% of cases of polycythemia vera (PV) and in about 50% of cases of essential thrombocythemia (ET). Recently, JAK2-exon 12 and MPL mutations have been reported
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::136a92ed898b66c793b3a6fc23b75146
https://doi.org/10.1182/blood.v114.22.1898.1898
https://doi.org/10.1182/blood.v114.22.1898.1898
Autor:
Marta González, Jose-Luis Bello, Jose Luis Dapena Díaz, Teresa González, Angeles Bendaña, Sandra Suaréz, Celsa Quinteiro, Natalia Alonso, Manuel Pérez-Encinas, Marta Anna Sobas
Publikováno v:
Blood. 112:5250-5250
Introduction: The JAK2V617F mutation is frequent in MPN, however its clinical implication is still in debate. There are few publications that analyze changes in JAK2V617F allele burden. Methods: We performed a single centre study on 65 patients (19 p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9259db3bed74eec72cedafe9e755b6af
https://doi.org/10.1182/blood.v112.11.5250.5250
https://doi.org/10.1182/blood.v112.11.5250.5250
Publikováno v:
Blood. 108:5347-5347
INTRODUCTION Plasma cell leukemia (PCL) is a rare disorder, characterized by circulating clonal plasma cell. It accounts for less than 1% of all plasma cell dyscrasias and has a fatal prognosis. It can be primary or secondary, when there was a previo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5c4b22b05ca8e7c2a873a0412eb63de0
https://doi.org/10.1182/blood.v108.11.5347.5347
https://doi.org/10.1182/blood.v108.11.5347.5347
Publikováno v:
Blood. 108:5266-5266
INTRODUCTION Graft versus host disease (GVHD) occurs when immunologycally competent cells are introduced into an immunoincompetent host. GVHD refers to both the immunologic insult and the consequences to the organism. The leading cause of GVHD is hem
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f07d7f7f37305c4566a3134ec7e243eb
https://doi.org/10.1182/blood.v108.11.5266.5266
https://doi.org/10.1182/blood.v108.11.5266.5266
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.